Waseem Hajjar | Clinical Medicine | Innovative Research Award

Innovative Research Award

Waseem Hajjar — King Saud University, Saudi Arabia

Researcher Profile
Researcher Waseem Hajjar
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 35518559800
Documents 76
Citations 1,154
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0001-7916-972X

Waseem Hajjar is a researcher affiliated with King Saud University, Saudi Arabia. The supplied academic profile identifies 76 documents, 1,154 citations, and an h-index of 17. His scholarly identity is additionally represented through persistent ORCID, Scopus, and Google Scholar profiles. The Innovative Research Award profile presented here summarizes the supplied bibliometric and institutional information in a neutral academic format.

Abstract

Waseem Hajjar is a clinical medicine researcher affiliated with King Saud University, Saudi Arabia, whose scholarly record includes 76 indexed documents, 1,154 citations, and an h-index of 17 according to the supplied profile data. His research portfolio reflects sustained engagement with clinical research and scholarly communication. The Innovative Research Award profile recognizes his documented research activity, publication record, citation impact, and professional presence across academic platforms. His ORCID, Scopus, and Google Scholar identifiers provide persistent links for verification and facilitate discovery of his scholarly contributions. This page summarizes the supplied academic information and presents it in a neutral format internationally.

Keywords

Clinical medicine; clinical research; medical research; healthcare research; evidence-based medicine; biomedical research; academic publishing; research collaboration; scholarly communication; research impact; citation analysis; Scopus; ORCID; Google Scholar; King Saud University; Saudi Arabia; innovative research; medical science; health sciences.

Introduction

Waseem Hajjar’s academic profile is presented within the context of clinical medicine and scholarly research. The supplied information identifies King Saud University as his institutional affiliation and Saudi Arabia as his country. Bibliometric indicators provide a concise description of indexed research activity, while persistent identifiers enable readers to distinguish and verify the researcher’s scholarly record across major academic platforms. Scopus provides author-level indexing and citation information, whereas ORCID supplies a persistent researcher identifier.

Research Profile

Waseem Hajjar is affiliated with King Saud University in Saudi Arabia and is identified in Scopus by author ID 35518559800. The supplied profile records 76 documents, 1,154 citations, and an h-index of 17. His identifiers across Scopus and ORCID support consistent attribution and scholarly profile discovery within academic databases internationally. These platforms provide complementary approaches to discovering publications, citations, author identifiers, and scholarly outputs. Bibliographic databases may differ in coverage and indexing practices, so individual records should be consulted when precise publication-level information is required. [1]

Research Contributions

Waseem Hajjar’s research contributions can be described through documented publication activity in clinical medicine and the associated citation record. Metrics indicate sustained scholarly output rather than one contribution. Interpretation of research themes should rely on individual publications, methodologies, findings, clinical contexts, and independently documented evidence from relevant literature and sources. Assessment of clinical research contributions generally requires consideration of study design, methodological rigor, reproducibility, clinical relevance, and the extent to which findings contribute to established knowledge.  [2]

Publications

Waseem Hajjar’s publication record contains 76 documents in the supplied Scopus profile. These publications provide evidence to evaluate research themes, methods, collaborations, and clinical relevance. Because publication titles and bibliographic details were not supplied here, this section avoids assigning topics and instead directs readers to the author record for verification. The supplied document count should be understood as a database-specific indicator rather than a complete inventory of every scholarly output.  [1]

Research Impact

Waseem Hajjar’s supplied citation indicators include 1,154 citations and an h-index of 17. These measures provide quantitative descriptions of scholarly visibility within the indexed record, while interpretation depends on field, publication age, database coverage, collaboration patterns, and citation practices. They should therefore be considered alongside publication-level evidence and contextual assessment. Citation indicators are commonly used to describe patterns of scholarly attention, but they have recognized limitations. [3]

Award Suitability

Waseem Hajjar’s profile contains identifiable academic credentials, indexed publications, citation indicators, and persistent researcher identifiers relevant to consideration for an Innovative Research Award. Award suitability should be determined from documented evidence, including originality, methodological quality, research contribution, reproducibility, and relevance of individual studies, rather than from bibliometric indicators alone. For a comprehensive award assessment, individual publications and supporting evidence should be reviewed alongside the supplied profile information. [4]

Conclusion

Waseem Hajjar’s supplied academic profile documents an affiliation with King Saud University, a Scopus author record containing 76 documents, 1,154 citations, and an h-index of 17, together with persistent ORCID and Google Scholar identifiers. These details provide a structured overview of scholarly activity. More detailed evaluation should be based on the underlying publications and independently verifiable research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Waseem Hajjar, Author ID 35518559800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35518559800
  2. ORCID. (n.d.). Waseem Hajjar — ORCID record.
    https://orcid.org/0000-0001-7916-972X
  3. Kaaki, S., Barnawi, A. B., Robaidi, H. A., Maghrabi, A. A., Almaymuni, A. D., Alzahim, A., Almahmoud, A., Alsalem, K. A., Alshehri, Y. M., Alsharari, H. S., & Hajjar, W. M. (2026). Perioperative outcomes and safety of uniportal robotic-assisted thoracic surgery (U-RATS) for anatomic lung resection: A systematic review and meta-analysis. https://link.springer.com/article/10.1007/s11701-026-03349-x
  4. Health Scientists Awards. (n.d.). Health Scientists Awards.
    https://healthscientists.org/
  5. Google Scholar. (n.d.). Waseem Hajjar — Google Scholar profile.
    https://scholar.google.com/citations?user=7s7wbfUAAAAJ&hl=en&oi=ao

Sibel Ozdemir | Pharmacology | Innovative Research Award

Innovative Research Award

Sibel Ozdemir — Yunus Emre State Hospital, Turkey

Sibel Ozdemir
Affiliation Yunus Emre State Hospital
Country Turkey
Scopus ID 60749146700
Subject Area Pharmacology
Event Health Scientists Awards
ORCID 0009-0003-4671-0964

Sibel Ozdemir is a researcher associated with Yunus Emre State Hospital whose recent scholarly work connects neurology with pharmacological investigation. Published studies have examined antiseizure medicines, experimental seizure models, medication combinations, and potential interactions involving clopidogrel, valproic acid, and levetiracetam. [1] [2]

Abstract

Sibel Ozdemir is a researcher affiliated with Yunus Emre State Hospital in Turkey whose documented work addresses pharmacology, neurology, and experimental seizure research. Her recent publications examine interactions between antiplatelet and antiseizure medicines and pharmacological effects in experimental models. This profile summarizes her research themes, publications, and recognition context in research.

Keywords

Epilepsy, valproic acid, levetiracetam, clopidogrel, pentylenetetrazol, freezing behavior, antiseizure medicines, anticonvulsant efficacy, experimental seizure models, behavioral effects, drug interactions, neurology, pharmacology, and clinical pharmacology. These terms reflect the themes identified in her recent research publications. [1] [2]

Introduction

Sibel Ozdemir is affiliated with the Department of Neurology at Yunus Emre State Hospital, Eskişehir, Türkiye. Her recent scholarly record includes investigations involving antiseizure medicines, drug interactions, and neurological models. These studies connect clinical neurology with pharmacological questions concerning treatment combinations and biological responses in experimental research settings. [1] [2]

Research Profile

Sibel Ozdemir’s documented research profile centers on neurology and pharmacology, with publications involving antiseizure therapy, experimental seizure models, and medication interactions. PubMed records identify her ORCID as 0009-0003-4671-0964 and associate recent work with Yunus Emre State Hospital. The available evidence supports a clinically oriented pharmacological research profile in clinical practice. [1]

Research Contributions

Sibel Ozdemir contributes to research examining pharmacological effects in neurological conditions. A 2026 study evaluated clopidogrel alongside valproic acid and levetiracetam in a pentylenetetrazol-induced seizure model, while another study examined differential effects of valproic acid and levetiracetam on freezing behavior. These studies address medication efficacy and drug interactions in pharmacology. [1] [2]

Publications

Sibel Ozdemir is listed as an author on publications concerning antiseizure pharmacology and neurological experimental models. Her 2026 International Journal of Molecular Sciences article investigated clopidogrel with valproic acid and levetiracetam, while a 2026 Journal of Biotechnology and Strategic Health Research article examined valproic acid and levetiracetam effects in rats. [1] [2]

Research Impact

Sibel Ozdemir’s research has potential relevance to pharmacological decision-making by investigating how neurological medicines behave in experimental combinations. The documented studies provide evidence about antiseizure efficacy and medication interactions, while their experimental designs also illustrate translational questions that may require further clinical investigation before broader conclusions are drawn. [1] [2]

Award Suitability

Sibel Ozdemir’s publication activity aligns with an Innovative Research Award profile through its focus on pharmacological questions in neurological research and experimental models. The publications demonstrate investigation of drug combinations and antiseizure effects. Award recognition should consider originality, methodological contribution, publication record, and relevance of the submitted research evidence overall. [1] [2]

Conclusion

Sibel Ozdemir’s available scholarly record presents a research trajectory connecting clinical neurology with pharmacology and experimental seizure research. Her recent publications provide documented evidence of work on antiseizure medicines and drug interactions. Continued publication, independent validation, and clinical translation would further clarify the broader significance of these research contributions today. [1] [2]

References

    1. Özdemir, S., Bolayır, E., & Şahin İnan, Z. D. (2026). Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model. International Journal of Molecular Sciences, 27(14), 6415.
      https://doi.org/10.3390/ijms27146415
    2. Gürkan, İ. M., Demir Cevizlidere, B., Çalişkan, S., Özdemir, S., & Özdemir, H. (2026). Effects of nano-hydroxyapatite-coated PRF on gingiva-derived mesenchymal stem cells: In vitro study. International Journal of Molecular Sciences, 27(13), 5736.
      https://doi.org/10.3390/ijms27135736
    3. ORCID. (n.d.). ORCID record: Sibel Ozdemir, ORCID 0009-0003-4671-0964.
      https://orcid.org/0009-0003-4671-0964
    4. Elsevier. (n.d.). Scopus author details: Sibel Ozdemir, Author ID 60749146700. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=60749146700

Raphael Duval | Pharmacology | Research Excellence Award

Prof. Dr. Raphael Duval | Pharmacology | Research Excellence Award

Dean | Université de Lorraine | France

Raphaël E. Duval is a senior academic leader and clinical microbiologist serving as Professor and Dean of the Faculty of Pharmacy at Université de Lorraine, France. His expertise spans infectiology, virology, cellular biology, and pharmaceutical sciences, with a strong focus on the discovery and development of innovative anti-infective and anticancer therapeutic agents. His research is widely disseminated through international peer-reviewed journals, scholarly book chapters, patents, and invited scientific communications, reflecting significant academic influence and citation impact. He actively collaborates with multidisciplinary teams across academia and industry at national and international levels. Recognized through prestigious scientific awards and fellowships, his work contributes to advancing therapeutic innovation, strengthening infectious disease management, and addressing major public health challenges with meaningful societal and clinical impact. He has 4909 citations from 98 documents with an h-index of 34.

Citation Metrics (Scopus)

4909
3500
2000
1000
0

Citations

4,909

Documents

98

h-index

34

Citations

Documents

h-index

View Google Scholar Profile
View Scopus Profile
View Orcid Profile

Featured Publications